AgomAb Therapeutics NV (AGMB) stock
Close on Nov 13, 2026Market cap $159.00KP/E –Yield –
AgomAb Therapeutics statistics
45 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Dec 31, 2025
- Share price as of
- –
Valuation ratiosIndustry
- P/TBV Ratio
- 0.00
- 1.33
Share statisticsIndustry
- Shares Change (YoY)
- 0.00%
- 5.61%
Short sellingIndustry
- Short Interest
- 920,851
- –
- Short Interest Change
- -2.24%
- -2.55%
- Days to Cover
- 7.44
- 3.54
Stock price statisticsIndustry
- Price Change (1 Week)
- -16.7%
- 0.08%
- Price Change (1 Month)
- -23.6%
- -2.76%
- Price Change (3 Months)
- -53.5%
- -21.7%
- Price Change (6 Months)
- -39.7%
- -11.3%
- Average Volume (10 Days)
- 441,772
- –
- Average Volume (20 Days)
- 285,963
- –
- Average Volume (90 Days)
- 167,664
- –
- Relative Volume
- 1.16
- 0.63
- Relative Strength Index (14)
- 29.1
- 48.4
- Volatility (1 Year)
- 90.6%
- 65.2%
Returns on capitalIndustry
- Return on Equity (ROE)
- -39.2%
- -15.4%
- Return on Assets (ROA)
- -34.7%
- -1.57%
- Return on Invested Capital (ROIC)
- -153.3%
- 6.28%
- Return on Capital Employed (ROCE)
- -43.9%
- -23.8%
Financial positionIndustry
- Current Ratio
- 6.52
- 3.49
- Quick Ratio
- 4.65
- 1.51
- Interest Coverage
- -445.68
- -0.71
EfficiencyIndustry
- Profits Per Employee
- -€1.01M
- -€43.26K
- Employee Count
- 62
- 304
Income statement (TTM)Industry
- Pretax Income
- -€62.55M
- -€47.40M
Balance sheetIndustry
- Net Cash (Debt)
- €86.42M
- €111.50M
- Net Cash Per Share
- 3456.72 EUR
- 1.53 EUR
- Equity (Book Value)
- €130.90M
- €472.30M
- Book Value Per Share
- 5236.08 EUR
- 6.00 EUR
- Tangible Book Value
- €102.18M
- €50.66M
- Working Capital
- €102.65M
- €119.55M
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Earnings Yield
- -43877.3%
- -1.80%
Taxes and interestIndustry
- Interest Expense
- €133.00K
- €55.20M
Scores and fair valueIndustry
- Altman Z-Score
- -0.47
- 1.23
- Piotroski F-Score
- 3
- 5
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | AGMB | S&P 500 | Difference | AGMB per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -27.8% | -3.0% | −24.8 pts | ||
| 3 months | -54.4% | -2.8% | −51.6 pts | ||
| Year to date | +63500.0% | +11.5% | +63488.5 pts | ||
| 1 year | +63500.0% | +13.5% | +63486.5 pts | ||
| 3 years | +63500.0% | +77.7% | +63422.3 pts | +760.0% | +21.1% |
| 5 years | +63500.0% | +72.6% | +63427.4 pts | +263.7% | +11.5% |
| 10 years | +63500.0% | +308.2% | +63191.8 pts | +90.7% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
1M AGMB shares were sold short on Oct 30, 2026, down 2.2% from the previous report. At recent volumes it would take 7.4 days to buy them back. Over the last 20 sessions, 12.3% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 920,851 | -2.2% | 123,797 | 7.4 |
| Oct 15, 2026 | 941,904 | -5.9% | 177,913 | 5.3 |
| Sep 30, 2026 | 1,001,145 | +15.4% | 140,678 | 7.1 |
| Sep 15, 2026 | 867,701 | -1.2% | 188,471 | 4.6 |
| Aug 31, 2026 | 878,372 | -6.7% | 129,785 | 6.8 |
| Aug 14, 2026 | 941,121 | -21.9% | 121,563 | 7.7 |
| Jul 31, 2026 | 1,204,962 | -3.0% | 64,345 | 18.7 |
| Jul 15, 2026 | 1,241,839 | -0.1% | 85,327 | 14.6 |
| Jun 30, 2026 | 1,242,788 | +16.2% | 142,181 | 8.7 |
| Jun 15, 2026 | 1,069,484 | +35.2% | 116,807 | 9.2 |
| May 29, 2026 | 791,046 | +2.6% | 42,925 | 18.4 |
| May 15, 2026 | 771,266 | +2.2% | 85,362 | 9.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?